We found that immune-related pathways, such as TNFA-signaling-via-NFKB, TGF-BETA signaling, IFN-γ response, IFN-α response, inflammatory response, and allograft-rejection pathways were significantly enriched in most blood cancers. This evidence concerns the gene IFNG and hematopoietic and lymphoid system neoplasm.